Radiology. Imaging cancer最新文献

筛选
英文 中文
Effects of CT-guided Radiofrequency Versus Microwave Ablation on Pulmonary Function in Individuals with Pulmonary Tumors: A Prospective Multicenter Randomized Trial. ct引导下射频与微波消融对肺肿瘤患者肺功能的影响:一项前瞻性多中心随机试验。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.260075
Gang Wang, Guoliang Xue, Zhigang Wei, Xueqin Gao, Yuliang Li, Jiayuan Sun, Jiansong Ji, Zhengyu Lin, Yunchao Huang, Xin Ye
{"title":"Effects of CT-guided Radiofrequency Versus Microwave Ablation on Pulmonary Function in Individuals with Pulmonary Tumors: A Prospective Multicenter Randomized Trial.","authors":"Gang Wang, Guoliang Xue, Zhigang Wei, Xueqin Gao, Yuliang Li, Jiayuan Sun, Jiansong Ji, Zhengyu Lin, Yunchao Huang, Xin Ye","doi":"10.1148/rycan.260075","DOIUrl":"10.1148/rycan.260075","url":null,"abstract":"<p><p>Purpose To compare short-term changes in pulmonary function after radiofrequency ablation (RFA) versus microwave ablation (MWA) in participants being treated for pulmonary tumors. Materials and Methods This prospective, multicenter, randomized trial (Chinese Clinical Trial Registry no. ChiCTR2400079813) included participants who underwent CT-guided RFA or MWA between November 2023 and July 2024 at six institutions. Pulmonary function tests, including vital capacity, forced vital capacity, forced expiratory volume in 1 second (FEV<sub>1</sub>), percentage of predicted FEV<sub>1</sub>, maximum midexpiratory flow, and single-breath diffusing capacity for carbon monoxide, were performed at baseline and 1 month after ablation. Secondary outcomes included procedure time, complications, and ablation completion rate. Intergroup comparisons and intragroup changes were analyzed. Results Overall, 138 participants with pulmonary tumors (mean age ± SD, 61.9 years ± 9.4; 72 female) were randomly assigned to undergo CT-guided RFA (<i>n</i> = 46) or MWA (<i>n</i> = 92). There was no evidence of a difference between the RFA and MWA groups for any pulmonary function parameter at baseline and at 1 month after ablation (eg, mean FEV<sub>1</sub> for RFA vs MWA, 2.27 L ± 0.70 vs 2.26 L ± 0.64 at baseline [<i>P</i> = .92]; 2.24 L ± 0.60 vs 2.20 L ± 0.60 at 1 month [<i>P</i> = .77]), nor was there evidence of a difference in pulmonary function parameters within each group (eg, mean FEV<sub>1</sub> with RFA, <i>P</i> = .32; mean FEV<sub>1</sub> with MWA, <i>P</i> = .10). The mean procedure time was significantly shorter for MWA than for RFA (48.1 vs 61.4 minutes, respectively; <i>P</i> = .004). The rates of major complications were similar between the two groups (eg, pneumothorax requiring chest tube drainage [20% for MWA vs 26% for RFA; <i>P</i> = .38]). Complete ablation rates were high for both techniques (98% [90 of 92] for MWA vs 93% [43 of 46] for RFA; <i>P</i> = .33). Conclusion RFA and MWA demonstrated similar short-term influences on pulmonary function in participants with pulmonary tumors; however, MWA was associated with a shorter procedure time, with outcomes similar to those seen with RFA. <b>Keywords:</b> Interventional-Oncology, Pulmonary Tumor, Radiofrequency Ablation, Microwave Ablation, Pulmonary Function <i>Supplemental material is available for this article.</i> Chinese Clinical Trial Registry no. ChiCTR2400079813 © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e260075"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretable Artificial Intelligence for the Assessment of Mass Margin and Malignancy on Mammograms: A Reader Study. 可解释的人工智能对乳房x光片肿块边缘和恶性程度的评估:一项读者研究。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.250736
Luke Moffett, Alina Jade Barnett, Yanchen Jessie Ou, Giyoung Kim, Joshua Boulter, Sujata Ghate, Connie Kim, Eun Langman, Abigail Lin, Marybeth Anderson Nedrud, Derek L Nguyen, Theresa Pham, Lars Grimm, Fides Regina Schwartz, Cynthia Rudin, Joseph Y Lo
{"title":"Interpretable Artificial Intelligence for the Assessment of Mass Margin and Malignancy on Mammograms: A Reader Study.","authors":"Luke Moffett, Alina Jade Barnett, Yanchen Jessie Ou, Giyoung Kim, Joshua Boulter, Sujata Ghate, Connie Kim, Eun Langman, Abigail Lin, Marybeth Anderson Nedrud, Derek L Nguyen, Theresa Pham, Lars Grimm, Fides Regina Schwartz, Cynthia Rudin, Joseph Y Lo","doi":"10.1148/rycan.250736","DOIUrl":"https://doi.org/10.1148/rycan.250736","url":null,"abstract":"<p><p>Purpose To examine whether readers incorporate artificial intelligence explanations into their reasoning when assessing masses with mammography. Materials and Methods In an observer study, eight readers from April to August 2024 (four attending breast radiologists and four trainees) retrospectively interpreted 140 mammographic masses for malignancy. Readers were aided by a two-stage artificial intelligence system. The first stage classified mass margins, and the second estimated malignancy likelihood (0%-100%). Readers classified malignancy using two interfaces: a black-box interface providing only the malignancy score and an interpretable interface that also provided the margin assessment and a prototype-based explanation (based on a similar training mass). In both settings, malignancy scores were systematically underestimated. Regression analysis assessed reader-model agreement, and receiver operating characteristic curve analysis assessed diagnostic performance. Results Trainees agreed more often with interpretable margin categories (60.0% [337 of 560]) than black-box margin categories (43.9% [246 of 560]; Holm-Bonferroni adjusted <i>P</i> (<i>P<sub>holm</sub>)</i> < .001). When the model presented underestimated malignancy scores, trainees provided proportionally underestimated scores (β = 0.93; <i>P<sub>holm</sub></i> < .001; 95% CI: 0.53, 1.33). Attending physicians also agreed more often with interpretable margin categories (interpretable, 55.0% [302 of 549]; black-box, 45.9% [257 of 560]; <i>P<sub>holm</sub></i> < .001), but their malignancy scores were not associated with the model's bias (β = 2.00; <i>P<sub>holm</sub></i> < .001; 95% CI: 1.40, 2.80). Malignancy performance showed no evidence of difference between interfaces for either trainees (black-box area under the receiver operating characteristic curve [AUC], 0.75; 95% CI: 0.68, 0.82; interpretable AUC, 0.76; 95% CI: 0.72, 0.80; <i>P<sub>holm</sub></i> = .64) or attending physicians (black-box AUC = 0.80; 95% CI: 0.75, 0.85; interpretable AUC = 0.77; 95% CI: 0.72, 0.83; <i>P<sub>holm</sub></i> = .64). Conclusion Both trainees and attending physicians were influenced by the artificial intelligence model's mass margin assessment. However, only trainees were influenced by the black-box malignancy model's predictions. <b>Keywords:</b> Decision Support, Mammography, Classification, Computer Aided Diagnosis (CAD), Breast <i>Supplemental material is available for this article.</i> © RSNA, 2026.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e250736"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonenhancing Leptomeningeal Metastasis: The Bloomy Rind Sign. 非增强性薄脑膜转移:布卢姆瑞德征。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.260388
Zhao Hui Chen Zhou, Carmen Lechuga Vázquez, Ana Ramos
{"title":"Nonenhancing Leptomeningeal Metastasis: The Bloomy Rind Sign.","authors":"Zhao Hui Chen Zhou, Carmen Lechuga Vázquez, Ana Ramos","doi":"10.1148/rycan.260388","DOIUrl":"https://doi.org/10.1148/rycan.260388","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e260388"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal Prostate-specific Membrane Antigen-avid Cholangiocarcinoma Mimicking Prostate Cancer Metastases. 多灶性前列腺特异性膜抗原胆管癌模拟前列腺癌转移。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.260467
Enes Yerdes, Ertan Sahin
{"title":"Multifocal Prostate-specific Membrane Antigen-avid Cholangiocarcinoma Mimicking Prostate Cancer Metastases.","authors":"Enes Yerdes, Ertan Sahin","doi":"10.1148/rycan.260467","DOIUrl":"https://doi.org/10.1148/rycan.260467","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e260467"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The EMERALD-3 Trial: STRIDE with or without Lenvatinib plus TACE for Embolization-eligible Hepatocellular Carcinoma. EMERALD-3试验:STRIDE联合或不联合Lenvatinib + TACE治疗符合栓塞条件的肝癌。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.269025
Ridvan A Demirci, Gustavo H Andrade
{"title":"The EMERALD-3 Trial: STRIDE with or without Lenvatinib plus TACE for Embolization-eligible Hepatocellular Carcinoma.","authors":"Ridvan A Demirci, Gustavo H Andrade","doi":"10.1148/rycan.269025","DOIUrl":"https://doi.org/10.1148/rycan.269025","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e269025"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging the Metastatic Niche: Superresolution US of Lymph Node Microvasculature. 转移生态位的成像:淋巴结微血管的超分辨率超声。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-11-01 DOI: 10.1148/rycan.260570
Mohammad Mirza-Aghazadeh-Attari
{"title":"Imaging the Metastatic Niche: Superresolution US of Lymph Node Microvasculature.","authors":"Mohammad Mirza-Aghazadeh-Attari","doi":"10.1148/rycan.260570","DOIUrl":"https://doi.org/10.1148/rycan.260570","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 6","pages":"e260570"},"PeriodicalIF":7.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Needle Insertion for CT-guided Percutaneous Biopsy of Thoracoabdominal Lesions: A Prospective Multicenter Randomized Trial. 机器人针插入在ct引导下经皮穿刺胸腹病变:一项前瞻性多中心随机试验。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-09-01 DOI: 10.1148/rycan.260054
Haozhe Huang, Chao Chen, Ying Wang, Lichao Xu, Hua Jiang, Hui Zeng, Wentao Li
{"title":"Robotic Needle Insertion for CT-guided Percutaneous Biopsy of Thoracoabdominal Lesions: A Prospective Multicenter Randomized Trial.","authors":"Haozhe Huang, Chao Chen, Ying Wang, Lichao Xu, Hua Jiang, Hui Zeng, Wentao Li","doi":"10.1148/rycan.260054","DOIUrl":"10.1148/rycan.260054","url":null,"abstract":"<p><p>Purpose To compare safety and feasibility between a novel CT-guided robotic system and the conventional freehand technique for puncture biopsy of thoracoabdominal lesions. Materials and Methods In this prospective multicenter randomized trial, individuals with suspected lesions were enrolled between July 2023 and April 2024 across three university teaching hospitals and randomized to the robot-assisted group (<i>n</i> = 82) or the freehand group (<i>n</i> = 83). Procedure outcomes included the technical success rate, targeting error, number of CT scans and needle adjustments, puncture time, and complications. Descriptive and inferential statistics were calculated. Results A total of 165 participants (mean age, 60 years ± 10 [SD]; 83 male) were included. Compared with the freehand group, the robot-assisted group demonstrated a higher technical success rate (97.56% [80 of 82] vs 62.65% [52 of 83], <i>P</i> < .001), lower targeting error (mean Euclidean deviation: 1.7 mm ± 1.1 vs 4.5 mm ± 3.9, <i>P</i> < .001), and fewer CT scans (mean, 4.3 ± 1.9 vs 5.2 ± 2.3; <i>P</i> = .002) and needle adjustments (mean, 0.7 ± 0.7 vs 1.6 ± 1.6; <i>P</i> = .003). Despite differences in geometric precision, both groups achieved 100% (82 of 82 and 83 of 83) diagnostic yield. The median puncture time was comparable between groups (5.5 minutes ± 4.3 vs 4.8 minutes ± 7.0, <i>P</i> = .50). During lung biopsies, the robot-assisted approach yielded fewer complications compared with the freehand approach (4.88% [four of 82] vs 16.87% [14 of 83], <i>P</i> = .014). Conclusion Compared with the freehand approach, robot-assisted biopsy yielded greater precision and reduced adjustments and complications while demonstrating noninferior diagnostic efficacy and comparable duration. <b>Keywords:</b> Robotic Needle Insertion, Biopsy, Thoracoabdominal Lesions, Robot-assisted Biopsy, CT-guided Intervention, Percutaneous Needle Biopsy, Randomized Controlled Trial, Algorithm Development, CT, Clinical Testing, Interventional-Body, Biopsy/Needle Aspiration, Percutaneous, Thorax, Abdomen/GI, Liver, Lung, Kidney ©RSNA, 2026.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 5","pages":"e260054"},"PeriodicalIF":7.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13620318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma? 谱CT能补充活检对食管胃交界腺癌的MSI/dMMR评估吗?
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-09-01 DOI: 10.1148/rycan.260534
Ramiro J Méndez, Ángel Nava
{"title":"Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma?","authors":"Ramiro J Méndez, Ángel Nava","doi":"10.1148/rycan.260534","DOIUrl":"10.1148/rycan.260534","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 5","pages":"e260534"},"PeriodicalIF":7.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13620321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149040469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MR Virtual Cytometry for Zone-specific Prostate Cancer Characterization with Histologic and Molecular Validation. 磁共振虚拟细胞术用于区域特异性前列腺癌的组织学和分子鉴定。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-09-01 DOI: 10.1148/rycan.250662
Jie Lu, Hao Cheng, Haotian Li, Kuiyuan Liu, Haoan Xu, Ruicheng Ba, Ming Liu, Wei Zhang, Hui Zhu, Min Chen, Chunmei Li, Dan Wu
{"title":"MR Virtual Cytometry for Zone-specific Prostate Cancer Characterization with Histologic and Molecular Validation.","authors":"Jie Lu, Hao Cheng, Haotian Li, Kuiyuan Liu, Haoan Xu, Ruicheng Ba, Ming Liu, Wei Zhang, Hui Zhu, Min Chen, Chunmei Li, Dan Wu","doi":"10.1148/rycan.250662","DOIUrl":"10.1148/rycan.250662","url":null,"abstract":"<p><p>Purpose To evaluate time-dependent diffusion MRI (<i>t<sub>d</sub></i>-dMRI)-based virtual cytometry for characterizing prostatic lesions and assess its zone-specific diagnostic value. Materials and Methods In this prospective study, participants with clinical suspicion of PCa were enrolled between March 2023 and August 2024 for <i>t<sub>d</sub></i>-dMRI. By modeling prostate tissue as intra- and extracellular compartments, microstructural features, including intracellular volume fraction, cell diameter, cellularity, and transmembrane water exchange time, were estimated. Diagnostic performance was analyzed using a generalized linear mixed model to account for multiple lesions per participant. Validation included correlations with whole-slide histologic examination as the reference standard (<i>n</i> = 36) and prostate-specific membrane antigen (PSMA) PET (<i>n</i> = 27). Results A total of 117 male participants (mean age, 70.0 years ± 6.8 [SD]) contributing 199 lesions were analyzed. PCa showed elevated intracellular volume fraction, cellularity, and accelerated transmembrane water exchange compared with benign lesions (adjusted <i>P</i> < .05). Higher Gleason grades were associated with further increases in these parameters (odds ratio, 2.62, 2.43, and 0.62, respectively; <i>P</i> < .05). Zone-specific features included higher intracellular water diffusivity in the peripheral zone and smaller cell size in the transition zone (TZ) (all adjusted <i>P</i> < .05). The <i>t<sub>d</sub></i>-dMRI-derived cellularity index demonstrated the highest performance for discriminating PCa from benign lesions, particularly in the TZ (area under the receiver operating characteristic curve, 0.94), which improved to 0.96 when combined with the Prostate Imaging Reporting and Data System. Validation showed strong correlations with histopathologic examination (cancer only <i>r</i> = 0.81, <i>P</i> < .001) and PSMA PET (<i>r</i> = 0.74, <i>P</i> < .05). Conclusion In this study, <i>t<sub>d</sub></i>-dMRI-based MR virtual cytometry enabled quantitative characterization of cellular microstructure in prostate disease and improved diagnostic performance, particularly in the TZ. <b>Keywords:</b> MR-Diffusion-weighted Imaging, PET, Prostate, Tissue Characterization, Modeling <i>Supplemental material is available for this article.</i> © RSNA, 2026.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 5","pages":"e250662"},"PeriodicalIF":7.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13620325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148991224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pixels to Prognosis: Translating Synthetic MRI Radiomics into Clinical Practice for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. 像素到预后:将合成MRI放射组学转化为人类表皮生长因子受体2阳性乳腺癌的临床实践。
IF 7.2
Radiology. Imaging cancer Pub Date : 2026-09-01 DOI: 10.1148/rycan.260448
Chunhong Hu
{"title":"Pixels to Prognosis: Translating Synthetic MRI Radiomics into Clinical Practice for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.","authors":"Chunhong Hu","doi":"10.1148/rycan.260448","DOIUrl":"10.1148/rycan.260448","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 5","pages":"e260448"},"PeriodicalIF":7.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13620472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148797353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书